Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.
Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Linehan WM, Testa JR, Bellacosa A, Kopelovich L, Knudson AG. Peri S, et al. Among authors: devarajan k. Oncotarget. 2017 Mar 14;8(11):17628-17642. doi: 10.18632/oncotarget.12192. Oncotarget. 2017. PMID: 27682873 Free PMC article.
A mouse model recapitulating molecular features of human mesothelioma.
Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR. Altomare DA, et al. Among authors: devarajan k. Cancer Res. 2005 Sep 15;65(18):8090-5. doi: 10.1158/0008-5472.CAN-05-2312. Cancer Res. 2005. PMID: 16166281
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash.
Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Schilder RJ, et al. Among authors: devarajan k. Gynecol Oncol. 2009 Apr;113(1):21-7. doi: 10.1016/j.ygyno.2008.12.003. Epub 2009 Jan 21. Gynecol Oncol. 2009. PMID: 19162309 Free PMC article. Clinical Trial.
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.
Bellacosa A, Godwin AK, Peri S, Devarajan K, Caretti E, Vanderveer L, Bove B, Slater C, Zhou Y, Daly M, Howard S, Campbell KS, Nicolas E, Yeung AT, Clapper ML, Crowell JA, Lynch HT, Ross E, Kopelovich L, Knudson AG. Bellacosa A, et al. Among authors: devarajan k. Cancer Prev Res (Phila). 2010 Jan;3(1):48-61. doi: 10.1158/1940-6207.CAPR-09-0078. Cancer Prev Res (Phila). 2010. PMID: 20051372 Free PMC article.
Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.
Meireles SI, Esteves GH, Hirata R Jr, Peri S, Devarajan K, Slifker M, Mosier SL, Peng J, Vadhanam MV, Hurst HE, Neves EJ, Reis LF, Gairola CG, Gupta RC, Clapper ML. Meireles SI, et al. Among authors: devarajan k. Cancer Prev Res (Phila). 2010 Jun;3(6):707-17. doi: 10.1158/1940-6207.CAPR-09-0162. Epub 2010 Jun 1. Cancer Prev Res (Phila). 2010. PMID: 20515954 Free PMC article.
Novel surface targets and serum biomarkers from the ovarian cancer vasculature.
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G. Sasaroli D, et al. Among authors: devarajan k. Cancer Biol Ther. 2011 Aug 1;12(3):169-80. doi: 10.4161/cbt.12.3.16260. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21617380 Free PMC article.
161 results